Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Lung Therapeutics Inc.
DescriptionInhaled version of LT-01, a single chain urokinase plasminogen activator
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationAcute lung injury
Indication DetailsTreat acute lung injury
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today